Richard Hague

This profile gathers the share dealings of Richard Hague across 2 companies, led by Polarityte, Inc. and Anika Therapeutics, Inc. Over a trading history stretching from 4 February 2016 to 18 July 2022, the count stands at 47 filings.

No open-market purchase appears, only 10 sales worth €321k. Other entries cover 37 share grants.

The latest filing, published on 19 July 2022, reports a share grant of €687 in Polarityte, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.